Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2011005841) SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2011/005841 International Application No.: PCT/US2010/041182
Publication Date: 13.01.2011 International Filing Date: 07.07.2010
Chapter 2 Demand Filed: 08.11.2010
IPC:
A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
HOPE MEDICAL ENTERPRISES, INC. DBA HOPE PHARMACEUTICALS [US/US]; 16416 N. 92nd Street#125 Scottsdale, AZ 85260, US (AllExceptUS)
SHERMAN, Craig [US/US]; US (UsOnly)
SMITH, Catherine, Marie [US/US]; US (UsOnly)
WIRTZ, Kevin, Robert [US/US]; US (UsOnly)
SCHULZE, Erich [US/US]; US (UsOnly)
Inventors:
SHERMAN, Craig; US
SMITH, Catherine, Marie; US
WIRTZ, Kevin, Robert; US
SCHULZE, Erich; US
Agent:
INSOGNA, Anthony, M.; Jones Day 222 East 41st Street New York, NY 10017-6702, US
Priority Data:
61/223,99308.07.2009US
Title (EN) SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
(FR) COMPOSITIONS PHARMACEUTIQUES CONTENANT DU THIOSULFATE DE SODIUM
Abstract:
(EN) Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
(FR) La présente invention concerne le thiosulfate de sodium pharmaceutiquement acceptable et des compositions pharmaceutiques associées. L'invention concerne également des procédés permettant de déterminer le carbone organique non purgeable total présent dans un échantillon contenant du thiosulfate de sodium. L'invention concerne en outre des procédés permettant de produire du thiosulfate de sodium pharmaceutiquement acceptable. L'invention concerne en outre des procédés de traitement consistant en l'administration de thiosulfate de sodium pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2451435JP2012532824CA2767168JP2016153360AU2010270605EP3213756
JP6182622JP2017165758DK2451435ES2655883PT2451435